Literature DB >> 24659448

Reevaluation of survival and prognostic factors in pathologic stage I lung adenocarcinoma by the new 2009 TNM classification.

Xiaohong Fan, Xueyan Zhang, Huimin Wang, Bo Jin.   

Abstract

The incidence of lung adenocarcinoma has been increased significantly year by year. In this histologic type, complete surgical resection is commonly chosen as treatment method at the initial stages. However, the postoperative survival rate remains unsatisfactory even within the stage I. The purpose of this study is to investigate the factors related with prognosis in stage I lung adenocarcinoma after surgical resection. In this manuscript, a retrospective study was performed. Survival rates were calculated by the Kaplan-Meier method, and for multivariate analyses, Cox proportional hazards regression model was used. The results indicated that a total of 531 patients were included. Overall 5-year survival was 81.2 %. Age, sex, pathologic stage, T category, tumor size, differentiation, necrosis, visceral pleural invasion (VPI), lymphatic vessel or vascular invasion, and serum carcinoembryonic antigen (CEA) were significantly associated with 5-year overall survival of the patients with Kaplan-Meier analysis. Moreover, on multivariate analyses, seven variables were shown to be independent prognostic factors, including differentiation (hazard ratios (HR), 1.357), VPI (HR, 0.551), lymphatic vessel or vascular invasion (HR, 0.533), necrosis (HR, 1.671), age (HR, 1.519), pathological stage (HR, 4.477), and CEA (HR, 2.099). In conclusion, the most important prognostic factor is pathologic stage. Other adverse prognostic factors include differentiation, VPI, lymphatic vessel or vascular invasion, necrosis, age, and CEA.

Entities:  

Mesh:

Year:  2014        PMID: 24659448     DOI: 10.1007/s13277-014-1781-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

1.  Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?

Authors:  Fatih Selcukbiricik; Ahmet Bilici; Deniz Tural; Sibel Erdamar; Ozlem Soyluk; Evin Buyukunal; Fuat Demirelli; Suheyla Serdengecti
Journal:  Tumour Biol       Date:  2013-04-28

2.  Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.

Authors:  Zhifu Sun; Marie-Christine Aubry; Claude Deschamps; Randolph S Marks; Scott H Okuno; Brent A Williams; Hiroshi Sugimura; V Shane Pankratz; Ping Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

3.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

4.  Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings.

Authors:  Kazuya Takamochi; Junji Yoshida; Mitsuyo Nishimura; Tomoyuki Yokose; Satoshi Sasaki; Yutaka Nishiwaki; Kazuya Suzuki; Kanji Nagai
Journal:  Eur J Cardiothorac Surg       Date:  2004-05       Impact factor: 4.191

5.  Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.

Authors:  Timothy R Asmis; Keyue Ding; Lesley Seymour; Frances A Shepherd; Natasha B Leighl; Tim L Winton; Marlo Whitehead; Johanna N Spaans; Barbara C Graham; Glenwood D Goss
Journal:  J Clin Oncol       Date:  2008-01-01       Impact factor: 44.544

6.  Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma.

Authors:  Michael I Ebright; Maureen F Zakowski; Jocelyne Martin; Ennapadam S Venkatraman; Vincent A Miller; Manjit S Bains; Robert J Downey; Robert J Korst; Mark G Kris; Valerie W Rusch
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

7.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Authors:  Giorgio Vittorio Scagliotti; Purvish Parikh; Joachim von Pawel; Bonne Biesma; Johan Vansteenkiste; Christian Manegold; Piotr Serwatowski; Ulrich Gatzemeier; Raghunadharao Digumarti; Mauro Zukin; Jin S Lee; Anders Mellemgaard; Keunchil Park; Shehkar Patil; Janusz Rolski; Tuncay Goksel; Filippo de Marinis; Lorinda Simms; Katherine P Sugarman; David Gandara
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

Review 8.  Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?

Authors:  Themistokles Chamogeorgakis; Costas Ieromonachos; Emmanouil Georgiannakis; Dimitrios Mallios
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-07-18

9.  The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer.

Authors:  Eirini Thanopoulou; George Kotzamanis; Ioannis S Pateras; Nicholaos Ziras; Alexandros Papalambros; Theodoros Mariolis-Sapsakos; Fragiska Sigala; Elizabeth Johnson; Athanassios Kotsinas; Andreas Scorilas; Vassilis G Gorgoulis
Journal:  Tumour Biol       Date:  2012-05-06

Review 10.  The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.

Authors:  Masahiro Tsuboi; Tatsuo Ohira; Hisashi Saji; Kuniharu Miyajima; Naohiro Kajiwara; Osamu Uchida; Jitsuo Usuda; Harubumi Kato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2007-04       Impact factor: 1.520

View more
  7 in total

1.  Evaluation of the Radiomics Method for the Prediction of Atypical Adenomatous Hyperplasia in Patients With Subcentimeter Pulmonary Ground-Glass Nodules.

Authors:  Bin Wang; Preeti Hamal; Xue Meng; Ke Sun; Yang Yang; Yangyang Sun; Xiwen Sun
Journal:  Front Oncol       Date:  2021-08-05       Impact factor: 6.244

2.  An individual-based model for collective cancer cell migration explains speed dynamics and phenotype variability in response to growth factors.

Authors:  Damian Stichel; Alistair M Middleton; Kai Breuhahn; Franziska Matthäus; Benedikt F Müller; Sofia Depner; Ursula Klingmüller
Journal:  NPJ Syst Biol Appl       Date:  2017-03-03

3.  Extent of Visceral Pleural Invasion Affects Prognosis of Resected Non-small Cell Lung Cancer: A meta-analysis.

Authors:  Ting Wang; Chengya Zhou; Qinghua Zhou
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

4.  Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.

Authors:  Min Dong; Zengli Yang; Xingfang Li; Zhenxiang Zhang; Ankang Yin
Journal:  Yonsei Med J       Date:  2020-12       Impact factor: 2.759

5.  Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.

Authors:  Shanping Shi; Mingjun Xu; Yang Xi
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

6.  Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma.

Authors:  Wei-Ming Luo; Zheng-Yu Wang; Xin Zhang
Journal:  Cancer Cell Int       Date:  2018-04-19       Impact factor: 5.722

7.  Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm.

Authors:  Tianxiang Chen; Jizhuang Luo; Rui Wang; Haiyong Gu; Yu Gu; Qingyuan Huang; Yiyang Wang; Jiajie Zheng; Chang Gu; Xufeng Pan; Jun Yang; Yunhai Yang; Heng Zhao
Journal:  Oncotarget       Date:  2017-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.